GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (OCSE:NSIS B) » Definitions » Change In Prepaid Assets

Novonesis (Novozymes) B (OCSE:NSIS B) Change In Prepaid Assets : kr0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Novonesis (Novozymes) B Change In Prepaid Assets?

Novonesis (Novozymes) B's Change In Prepaid Assets for the quarter that ended in Mar. 2025 was kr0 Mil. It means Novonesis (Novozymes) B's Prepaid Assets stayed the same from Dec. 2024 to Mar. 2025 .

Novonesis (Novozymes) B's Change In Prepaid Assets for the fiscal year that ended in Dec. 2024 was kr0 Mil. It means Novonesis (Novozymes) B's Prepaid Assets stayed the same from Dec. 2023 to Dec. 2024 .

Novonesis (Novozymes) B Change In Prepaid Assets Historical Data

The historical data trend for Novonesis (Novozymes) B's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Change In Prepaid Assets Chart

Novonesis (Novozymes) B Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Prepaid Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Novonesis (Novozymes) B Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25
Change In Prepaid Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Novonesis (Novozymes) B Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novonesis (Novozymes) B Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis (Novozymes) B Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (OCSE:NSIS B) » Definitions » Change In Prepaid Assets
Comparable Companies
OCSE:SPG OCSE:FLUG B OCSE:HOVE LIN XPAR:AI SHW ECL APD ISX:TPIA XSWX:GIVN XSWX:SIKA DD XAMS:DSFIR BOM:500820 PPG SHSE:600309 ADX:BOROUGE IFF LYB TSE:4612
Traded in Other Exchanges
NVZMY:USA NVZMF:USA NSISBc:UK 0Q4U:UK NZM:Germany NZM:Germany NZM2:Germany NZM2:Germany NZYM:Austria
Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Website
https://www.novozymes.com
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

No Headlines